Funder
Centers for Disease Control and Prevention
Reference19 articles.
1. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019. U.S. Department of Health and Human Services, CDC; 2019. Accessed June 25, 2024. https://www.cdc.gov/antimicrobial-resistance/data-research/threats/index.html.
2. Centers for Disease Control and Prevention. COVID-19: U.S. Impact on antimicrobial resistance, Special Report 2022. U.S. Department of Health and Human Services, CDC; 2022. Accessed July 18, 2023. https://stacks.cdc.gov/view/cdc/119025 .
3. A Candida auris outbreak and its control in an intensive care setting;Eyre;N Engl J Med,2018
4. Control of Simultaneous Outbreaks of Carbapenemase-Producing Enterobacteriaceae and Extensively Drug-ResistantAcinetobacter baumanniiInfection in an Intensive Care Unit Using Interventions Promoted in the Centers for Disease Control and Prevention 2012 Carbapenemase-Resistant Enterobacteriaceae Toolkit
5. Increase in hospital-acquired carbapenem-resistant Acinetobacter baumannii infection and colonization in an acute care hospital during a surge in COVID-19 admissions - New Jersey, February-July 2020;Perez;MMWR Morb Mortal Wkly Rep,2020